Business
Theralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Disease
TORONTO, ON / ACCESSWIRE / February 12, 2024 / Theralase® Technologies Inc. (" Theralase&#x...
About this update from Theralase Technologies Inc.
[{"type":"text","content":"Theralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's DiseaseTORONTO, ON / ACCESSWIRE / February 12, 2024 / Theralase® Technologies Inc. (\"Theralase®\" or the \"Company\") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (\"PDCs\") for the safe and effective destruction of various cancers, bacteria and viruses, donated two Theralase® TLC-2400 Cool Laser Therapy (\"CLT\") systems to the University of Windsor to aid in the research and development of a novel treatment for patients suffering from Parkinson's Disease (\"Parkinson's\").Theralase® is working in collaboration with researchers at the University of Windsor, Faculty of Human Kinetics and a Windsor based chiropractor to conduct a groundbreaking clinical study into how Theralase® CLT can be used as a treatment for Parkinson's. Theralase®'s CLT, with its super-pulsed laser technology, is one of the few technologies in the world able to non-invasively penetrate the human skull, promoting anti-inflammatory responses and stimulating neurons to promote healing from this deadly disease.\"We're excited to begin the very first randomized placebo-controlled study on laser light therapy in Parkinson's patients,\" said kinesiology professor Anthony Bain, who is leading the clinical study together with professors Sean Horton, Paula van Wyk, Chad Sutherland and Windsor-based chiropractor Dr. Luigi Albano of Walkerville Chiropractic. Dr. Bain went on to say, \"We are especially grateful to be collaborating with Theralase® on the project and for their generous donation of the CLT technology.\"CLT is a very promising therapy, Dr. Bain added, stating, \"Preliminary studies and animal experiments exploring the use of CLT in Parkinson's have demonstrated positive outcomes, including potential improvements in motor function and a significant reduction in symptoms.\"Parkinson's is a neurological disorder in which the brain loses its ability to control movement. The first symptom is usually tremors, but as the disease progresses, people with Parkinson's may struggle with walking, talking, memory loss, chronic pain, fatigue, depression, anxiety, loss of the sense of smell and other n...